Videos

Bipolar and spring mania: tips from an expert.

"I go down the 58,022 names, half-expecting to find my own in letters like smoke."

Psychiatry experts unpack why off-label medications are common and how evidence and dosing guide care.

Learn how clinicians track depression outcomes using function, quality of life, and joy—tailoring treatment goals to each patient’s life.

Please paste the article text (or an excerpt). If you share the title too, I’ll avoid mirroring it while crafting a 150-character, ≤24-word meta description.

Clinicians reveal key TRD drivers—childhood trauma, comorbidities, family history, adherence gaps, and anhedonia—so treatment targets what matters.

Learn how narcolepsy mimics ADHD, seizures and depression, plus key clues, comorbid risks, and genetic triggers behind chronic sleepiness.

Psychiatrists share women who inspire them for Women's History Month.

"Today I am the oldest I have been..."

Explore how hidden moral injury fuels clinician burnout, why betrayal and bystander guilt linger, and what psychiatry suggests for healing.

New Sleep in America poll reveals kids fall short on sleep, parents underestimate needs, and family wellbeing suffers.

Experts explain why some depression resists standard meds, highlighting brain circuitry, inflammation, hormones, and the need for faster, more targeted treatment options.

Narcolepsy is more common than thought—often missed in sleep clinics, mistaken for ADHD or depression, causing 10–15 year delays.

Experts explain why some depression resists standard meds, urging faster, personalized care that targets brain circuits, inflammation, hormones, and neuromodulation.

Learn how narcolepsy shows up: true daytime sleepiness, subtle cataplexy, vivid dreams—and why kids are often misread as ADHD.

New expert guidance shows how to safely review and taper psychiatric medications, weighing efficacy, risks, interactions, and patient input in mood disorders.

"A 'Prior Auth' parasite dumps me on hold, sucks another hour from my life, one more chance to practice my 'Close-Your-Eyes- And-Imagine-a-Blank-Screen' coping skill..."

Preview APA meeting highlights: Steven Sharfstein’s humanitarian award, managed care lessons, and restoring balance beyond “bio-bio-bio” psychiatry.

Experts unpack why depression persists after multiple meds, how to spot true treatment resistance, and strategies to achieve full remission.

In this episode, 'Recognizing Narcolepsy Across the Lifespan', the experts explore the clinical presentation of narcolepsy, beginning with the one symptom universal to all patients: excessive daytime sleepiness.

Clinicians explain who meets TRD criteria, why residual symptoms drive relapse, and how to pursue full remission with real-world strategies.

In this episode titled, 'Understanding Narcolepsy as More Than a Sleep Disorder', the moderator, Dr. Karl Doghramji, led the conversation about excessive daytime sleepiness as a widespread clinical challenge, with the expert panel narrowing the focus to narcolepsy, a central disorder of hypersomnolence that is frequently missed in practice

AI may reshape psychiatry and clinical trials, but raises safety, regulation, and trust concerns.

Experts discuss why early treatment and tailored combos can curb bipolar disorder.

"If items of horror can make a man laugh then laugh at this: one hour later, the growth still undiscovered, ticking its own wild time..."

Compass Pathways reports COMP360 psilocybin shows fast, durable relief in treatment‑resistant depression. Guy Goodwin, MD, shares his insights.

An expert shares why new kratom variants have dangerous implications for substance use disorder.

Explore how a 1960s peace song, Yom Kippur reflection, and a landmark psychiatrists’ prayer shape today’s mental health spirituality.

Learn more about ADHD and its intersection with the emerging DMDD space.

Data show fast-acting psychedelic therapy for depression with lasting gains—plus the safety questions shaping its future.